Updated 13 May 2025 at 16:08 IST
Cipla Dividend FY25: Pharma company Cipla has announced that its Board of Directors has recommended a final dividend of Rs 13 per equity share for the financial year ended March 31, 2025. In addition, the company proposed a special dividend of Rs 3 per share to commemorate its 90th anniversary, bringing the total proposed dividend to Rs 16 per share (on a face value of Rs 2 each).
“The Board of Directors of the Company also recommended a final dividend of Rs 13/- per equity share for the financial year ended 31st March, 2025 and a special dividend of Rs 3/- per equity share on the occasion of completing 90 years of the Company, taking the total dividend to Rs 16/- per equity share (face value of Rs 2 each)," Cipla said in its filing to BSE.
The dividend is subject to shareholder approval at the upcoming Annual General Meeting (AGM), after which it will be paid within 30 days. The company has set June 27, 2025 as the record date for determining shareholders eligible for the final dividend.
In the previous years, Cipla has consistently rewarded shareholders with healthy payouts. In 2024, the company declared a dividend of Rs 13, up from Rs 8.50 in 2023 and Rs 5 in 2022, reflecting growing profitability and a shareholder-friendly approach.
Cipla reported its consolidated net profit for the quarter ended March 2025 at Rs 1,222 crore vis-a-vis Rs 939 crore in the corresponding quarter last year. The company's revenue from operations rose 9% YoY to Rs 6,729 crore, up from Rs 6,163 crore in the corresponding quarter of the previous fiscal.
Its total income came in at Rs 7,019.15 crore, up 9.45% against Rs 6,412.57 crore income seen in the March 2024 quarter. Further, the company’s EBITDA stood at Rs 1,537 crore for the March quarter of FY25, which also increased from Rs 1,316 crore registered in the same period of FY 24.
Cipla's shares went up marginally after the results were announced. The shares were up 0.5% to trade at Rs 1,519.20 apiece on the BSE.
Published 13 May 2025 at 14:00 IST